South and Central America In-Vitro Diagnostics Market Growth and Recent Trends by 2027

South and Central America In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027
  • Status : Published
  • Report Code : TIPRE00022126
  • Category : Life Sciences
  • No. of Pages : 195
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 06, 2021
South and Central America In-Vitro Diagnostics Market Growth and Recent Trends by 2027
Report Date: May 06, 2021   |   Report Code: TIPRE00022126 Email: sales@theinsightpartners.com

2019 Market Size

US$ 4,387.7 Mn

Base year value

2027 Forecast

US$ 5,820.0 Mn

Projected by 2027

CAGR 2020-2027

3.6 %

Growth rate

Addressable Market

US$ 41,292.47 Mn

(2020-2027)

The In-vitro diagnostics market in South and Central America is expected to grow from US$ 4,387.7 million in 2019 to US$ 5,820.0 million by 2027; it is estimated to grow at a CAGR of 3.6% from 2020 to 2027.



The region is witnessing exponential increase in prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Certain factors, such as poor sanitary conditions, lack of public hygiene, massive air pollution, and lack of safe drinking water, are playing a significant role in the increasing prevalence of infectious diseases. For instance, according to data published by the World Health Organization (WHO) in 2019, approximately 71.0 million people suffered from hepatitis C virus infection across the globe. Moreover, extreme globalization, intense mobility of the population, and persistent urbanization are expected to spread viral infections with greater ease. Since there is a lack of better public health surveillance systems and access to care, a substantial population in developing countries as well as remote regions, is highly prone to viral infections. This, combined with considerable growth in the viral epidemics, is projected to offer a high demand the in-vitro diagnostics (IVD) during the forecast period.

In the South and Central American region, countries like Brazil, Chile, and Peru have experienced significant incidences of COVID-19 patients. According to the Pan American Health Organization (PAHO), as of 12 June 2020, Brazil, Peru, and Chile had 5.1%, 2.8%, and 1.8% crude case fatality rates (CFR). Maximum deaths were observed in the age group 60 to 70+ years old. In addition. 60% of these deaths in this age group occurred in men. Therefore, considering the rise in the incidences have demanded IVD test kits and products. The biotechnology industry is growing in the countries that are expected to serve vital growth opportunities for the IVD market in the coming future.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the In-vitro diagnostics market. The South and Central America In-vitro diagnostics market is expected to grow at a good CAGR during the forecast period.


21790-img1

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

South and Central America In-Vitro Diagnostics Market Segmentation          

By Product and Services

  • Instruments
  • Reagents & Kits
  • Software & Services

By Technology

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation & Hemostasis
  • Hematology
  • Urinalysis
  • Others

By Application

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Others

By End User

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By Country

  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America

Companies Mentioned

  • F. HOFFMANN-LA ROCHE LTD.
  • DANAHER
  • ABBOTT
  • SIEMENS AG
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • BD
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN

South and Central America In-Vitro Diagnostics Report Scope

Report Attribute Details
Market size in 2019 US$ 4,387.7 Million
Market Size by 2027 US$ 5,820.0 Million
CAGR (2020 - 2027) 3.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product and Services
  • Reagents and Kits
  • Instruments
  • Software and Services
By Technology
  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation & Hemostasis
  • Hematology
  • Urinalysis
By Application
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
By End User
  • Hospitals
  • Laboratories
  • Homecare
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • F. HOFFMANN-LA ROCHE LTD.
  • DANAHER
  • ABBOTT
  • SIEMENS AG
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • BD
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA